Waycross Partners, LLC Abb Vie Inc. Transaction History

Waycross Partners, LLC

$772 Million
Q4 2024

A detailed history of Waycross Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Waycross Partners, LLC holds 135,004 shares of ABBV stock, worth $26.6 Million. This represents 3.11% of its overall portfolio holdings.

Number of Shares

135,004

Previous 130,985 3.07%

Holding current value

$26.6 Million

Previous $25.9 Million 7.25%

% of portfolio

3.11%

Previous 3.58%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$164.99 - $203.87 $663,094 - $819,353	4,019 Added 3.07%	135,004 $24 Million
Q3 2024 Nov 08, 2024	BUY	$163.84 - $199.33 $445,317 - $541,778	2,718 Added 2.12%	130,985 $25.9 Million
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $1.87 Million - $2.18 Million	12,086 Added 10.4%	128,267 $22 Million
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $1.04 Million - $1.19 Million	6,534 Added 5.96%	116,181 $21.2 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $702,035 - $790,656	-5,102 Reduced 4.45%	109,647 $17 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $621,594 - $719,586	4,653 Added 4.23%	114,749 $17.1 Million
Q2 2023 Jul 26, 2023	BUY	$132.51 - $164.9 $2.44 Million - $3.04 Million	18,433 Added 20.11%	110,096 $14.8 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $2.47 Million - $2.84 Million	17,067 Added 22.88%	91,663 $14.6 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $4.79 Million - $5.75 Million	34,641 Added 86.7%	74,596 $12.1 Million
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $38,249 - $43,870	-285 Reduced 0.71%	39,955 $5.36 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $323,131 - $410,806	2,348 Added 6.2%	40,240 $6.16 Million
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $455,858 - $565,592	3,454 Added 10.03%	37,892 $6.14 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $558,636 - $706,836	5,200 Added 17.79%	34,438 $4.66 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $2.91 Million - $3.3 Million	-27,362 Reduced 48.34%	29,238 $3.15 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $2.9 Million - $3.24 Million	27,611 Added 95.25%	56,600 $311 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $1.23 Million - $1.35 Million	12,000 Added 70.63%	28,989 $3.14 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $1.37 Million - $1.85 Million	16,989 New	16,989 $1.82 Million

Others Institutions Holding ABBV

# of Institutions

4,088

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waycross Partners, LLC with notifications on news.

Account

Waycross Partners, LLC Abb Vie Inc. Transaction History